Botulinum toxin type A

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Botulinum toxin type A and local guidelines before prescribing.

Neurotoxin

Mechanism

Blocks acetylcholine release at the neuromuscular junction.

Uses

Focal dystonia, spasticity, chronic migraine, hyperhidrosis, overactive bladder, strabismus, sialorrhoea.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Local weakness, injection-site pain, ptosis, dysphagia with neck injections, distant spread (rare).

Interactions

Aminoglycosides and neuromuscular blockers potentiate.

Contraindications and cautions

Infection at injection site, myasthenia gravis caution

Monitoring

Response, swallowing

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive; antitoxin only for systemic botulism

Special advice

Effect appears over days and lasts about 3 months; units are not interchangeable between brands.

More from the textbook: uses, cautions and other points
Where it is discussed in the book